Grethe R. Krog

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Variation in eluate volume during DNA extraction does not affect eluate concentration of plasma-derived DNA.

Variation in eluate volume during DNA extraction does not affect eluate concentration of plasma-derived DNA.

Journal: Blood transfusion = Trasfusione del sangue

Published: March 23, 2026

Blood donor genotyping for prediction of blood group antigens: Results from 5 years' experience (2017-2022).

Blood donor genotyping for prediction of blood group antigens: Results from 5 years' experience (2017-2022).

Journal: Vox sanguinis

Published: June 07, 2023

Reduced susceptibility to COVID-19 associated with ABO blood group and pre-existing anti-A and anti-B antibodies.

Reduced susceptibility to COVID-19 associated with ABO blood group and pre-existing anti-A and anti-B antibodies.

Journal: Immunobiology

Published: January 13, 2023

Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects.

Droplet digital PCR-based testing for donor-derived cell-free DNA in transplanted patients as noninvasive marker of allograft health: Methodological aspects.

Journal: PloS one

Published: December 21, 2022

Secretor status of blood group O mothers is associated with development of ABO haemolytic disease in the newborn.

Secretor status of blood group O mothers is associated with development of ABO haemolytic disease in the newborn.

Journal: Vox sanguinis

Published: December 13, 2022

ABO haemolytic disease of the newborn: Improved prediction by novel integration of causative and protective factors in newborn and mother.

ABO haemolytic disease of the newborn: Improved prediction by novel integration of causative and protective factors in newborn and mother.

Journal: Vox sanguinis

Published: May 10, 2021

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn.

Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn.

Journal: Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie

Published: April 21, 2021

Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.

Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.

Journal: Pediatric research

Published: May 20, 2020

Blood group genotyping of blood donors: validation of a highly accurate routine method.

Blood group genotyping of blood donors: validation of a highly accurate routine method.

Journal: Transfusion

Published: March 12, 2019

Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.

Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: December 04, 2018

Early and Accurate Sex Determination by qPCR of Y Chromosome Repetitive Sequence (YRS) In Cell-Free Fetal DNA from Maternal Plasma.

Early and Accurate Sex Determination by qPCR of Y Chromosome Repetitive Sequence (YRS) In Cell-Free Fetal DNA from Maternal Plasma.

Journal: The journal of applied laboratory medicine

Published: April 09, 2018

Non-invasive foetal RhD genotyping to guide anti-D prophylaxis: an external quality assurance workshop.

Non-invasive foetal RhD genotyping to guide anti-D prophylaxis: an external quality assurance workshop.

Journal: Blood transfusion = Trasfusione del sangue

Published: November 21, 2016

Showing 1-12 of 17

Last Updated: 09/26/2026